Skip to main content
OpenTrials
Completed

NCT Number: NCT03689088

Sensing Contact Lens-based Device for 24-hour Monitoring of Intraocular Pressure

Glaucoma is characterized by irreversible vision loss through the progressive death of optic nerve fibers unless timely diagnosis and adequate treatment are provided. Medical therapy is aimed at lowering intraocular pressure (IOP) below a clinically determined target level in order to prevent or slow glaucoma progression. IOP is known to vary with the time of day as well as with daily activities.

The current way of assessing nycthemeral IOP fluctuation is to perform repeated discrete tonometry measurements, allowing only snapshot and non-continuous measurements once per hour in the best cases. The procedure is cumbersome, expensive, inconvenient (disturbed sleep cycle as patient is awoken for nocturnal/sleep period measurements) and may not detect crucial IOP values in time.

Sensimed AG has developed a new contact lens (CL)-based device intended to continuously measure IOP over 24 hours. The objective of this study is to investigate the use of device for 24-hour IOP monitoring in healthy subjects and glaucoma patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Glaucoma, Open-Angle Eye Diseases Glaucoma Healthy Ocular Hypertension

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

[W]-Eye clinic

Poznan, 61-048, Poland

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • For Open Angle Glaucoma (OAG) subjects, a clinical diagnosis of primary OAG, including normal tension glaucoma (NTG) all known untreated IOP measurements < 22 mmHg using Goldmann Applanation Tonometry (GAT) for NTG no IOP-lowering treatment; otherwise, a 4-week wash-out period prior to the recording
  • For healthy subjects, no structural defects, normal visual fields, IOP ≤ 21 mmHg and open angles on gonioscopy
  • Aged ≥ 18 years, either gender
  • Body Mass Index ≤ 30 kg/m2
  • Central Corneal Radius (flat meridian) between 7.5 mm (45 D) and 7.9 mm (42.75 D)
  • Central Corneal Thickness between 500 microns and 600 microns
  • Difference in IOP absolute value between eyes within 2.5 mmHg at screening in sitting position
  • Same direction of IOP variation (positive or negative) for the 2 eyes when moving from sitting to supine positions at screening
  • Spherical refraction within ±6.00 diopters and cylinder refraction within ±3.00 diopters
  • Having given written informed consent, prior to any investigational procedures

Exclusion criteria

  • Ocular pathology (other than glaucoma for glaucoma subjects)
  • Previous glaucoma, cataract or refractive surgery
  • Corneal or conjunctival abnormality, precluding contact lens adaptation
  • Severe dry eye syndrome
  • Subjects with allergy to corneal anesthetic
  • Subjects with contraindications for silicone CL wear
  • Subjects with contraindications for Water Drinking Test (WDT) (eg., heart, renal problems)
  • Subjects unable or unwilling to comply with the study procedures
  • Participation in other interventional clinical research within the last 4 weeks

Treatment and study plan

Goldfish

Device

Goldfish will be placed in the eye for 24h monitoring

Tonometry

Device

Fellow eye will be measured by tonometry

Primary outcomes

  1. Changes in IOP assessed by Goldfish following known physiological and induced changes in IOP

    Time frame: 24 hours

    IOP will be measured using tonometry in the fellow eye and compared to IOP measured in the Goldfish eye with the Goldfish device

Secondary outcomes

  1. Percentage of subjects completing 24-hour session with Goldfish

    Time frame: 24 hours

    Percentage of subject completing the session will be calculated at the end of the study

  2. Wearing discomfort of Goldfish based on visual analogue scale

    Time frame: 24 hours

    Tolerability of the Goldfish lens will be subjectively evaluated before and after GF wear using a visual analogue scale from 0 (no discomfort) to 100 (severe discomfort) mm

  3. Evaluation of Goldfish technical performance based on the percentage of valid Goldfish measurements

    Time frame: 24 hours

    Percentage of valid measurement will be calculated at the end of each monitoring session

  4. Correlation between IOP and ocular pulse amplitude (OPA) assessed by Goldfish in the Goldfish eye and IOP and OPA measured by tonometry in the fellow eye

    Time frame: 24 hours

    OPA will be extracted from the Goldfish signal in the Goldfish eye and measured by tonometry in the fellow eye. Both IOP and OPA measurement will be compared between fellow eyes

  5. Relationship between Goldfish IOP and blood pressure (BP) measurements over 24 hours

    Time frame: 24 hours

    IOP signal acquired with Goldfish will be compared to BP signal assessed with a BP holter

Sponsors and collaborators

Lead sponsor

Sensimed AG

Industry

Registry information

Official study title

A Prospective Pilot Study Investigating the Use of a Sensing Contact Lens-based Device for 24-hour Monitoring of Intraocular Pressure in Healthy Subjects and Patients With Open Angle Glaucoma

Important dates

Study start
2018
Primary completion
2018
Study completion
2018
First posted
Sep 28, 2018
Registry last updated
Dec 4, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.